New Parkinson’s therapies aim to halt disease, not just symptoms

The introduction of levadopa therapy more than 40 years ago marked a milestone in the treatment of Parkinson’s disease. The dopamine replacement drug helps control the motor symptoms associated with the neurodegenerative disease, but it does not prevent the further loss of dopamine-producing neurons, so researchers have been on the hunt for more neuroprotective treatment options.

http://ping.fm/NIFT2